Gladwin, Mark, MD
13
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
46.2%
6 terminated/withdrawn out of 13 trials
53.8%
-32.7% vs industry average
0%
0 trials in Phase 3/4
129%
9 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Nitrites, Skeletal Muscle Mitochondrial Bioenergetics, and Physical Activity in Old Age
Role: lead
Chlorhexidine Mouthwash and Oral Nitrate in Adults With Pulmonary Hypertension
Role: lead
Transfusion of Biotin-Labeled Red Blood Cells
Role: lead
A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction
Role: lead
Oral CXA-10 in Pulmonary Arterial Hypertension
Role: lead
The Effects of NOx and Conjugated Linoleic Acid on Asthmatics
Role: lead
Oral Nitrite Trial for Hypertension and Metabolic Syndrome
Role: lead
Oral Nitrite for Older Heart Failure With Preserved Ejection Fraction
Role: lead
Oral Nitrite in Adults With Metabolic Syndrome and Hypertension
Role: lead
Oral Nitrite for Older Heart Failure Patients
Role: lead
Oral Nitrite and Nitrate in Healthy Normal Volunteer Adults
Role: lead
Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction
Role: lead
Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation
Role: lead
All 13 trials loaded